FindMyKOL

Larry Kilgore, MD

Basic profile

University of Tennessee Medical Center

ORCIDOn fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionKnoxville, TN · SoutheastSpecialtyGynecologic OncologyFocusOncology
Active KOLFindMyKOL type: RegionalLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Larry Kilgore is an Oncology physician affiliated with University of Tennessee Medical Center. OpenAlex indexes 90 publications with 3,341 citations (h-index 25).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
90publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

3,341citations

Citations across these publications.

25h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
21companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • GSK
    Program year20256 paymentsResearch
    $5,111
  • ABBVIE INC.
    Program year202510 payments
    $197
  • Merck Sharp & Dohme LLC
    Program year20255 payments
    $126
All 46 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    57.7%
    Serotonin-3 Receptor Antagonist57.7%
    Ondansetron Hcl100%
    Part D<11 patients
  • Genitourinary & hormones

    42.3%
    Estrogen42.3%
    Combipatch100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”